carbamazepine has been researched along with 2019 Novel Coronavirus Disease in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We carried out a systematic search for publications in English and Russian on the safety and efficacy of CMZ in depressive disorders of different etiologies in the PubMed, Web of Science, Springer, Clinical Keys, Google Schooler, E-Library databases using keywords and combined word searches (carbamazepine, COVID-19, depression, epilepsy, post-COVID-syndrome) for the period from January 01,2020 to June 10, 2022." | 9.22 | Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression. ( Cumming, P; Davydkin, I; Fedyashov, I; Gayduk, A; Nasyrova, R; Shnayder, N; Smirnova, D; Strelnik, A; Vaiman, E, 2022) |
| "We carried out a systematic search for publications in English and Russian on the safety and efficacy of CMZ in depressive disorders of different etiologies in the PubMed, Web of Science, Springer, Clinical Keys, Google Schooler, E-Library databases using keywords and combined word searches (carbamazepine, COVID-19, depression, epilepsy, post-COVID-syndrome) for the period from January 01,2020 to June 10, 2022." | 5.22 | Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression. ( Cumming, P; Davydkin, I; Fedyashov, I; Gayduk, A; Nasyrova, R; Shnayder, N; Smirnova, D; Strelnik, A; Vaiman, E, 2022) |
| " Cannabidiol (CBD) is increasingly used to treat epilepsy." | 5.12 | Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. ( Główka, AK; Główka, FK; Karaźniewicz-Łada, M; Mikulska, AA, 2021) |
| "Carbamazepine was administered for 11 weeks." | 1.72 | Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases. ( Alvarenga, RMP; Alves, MCDF; Gouvea, EG; Hammerle, MB; Pereira, TV; Pinheiro, PG; Pires, KL; Rueda Lopes, FC; Sales, DS; Schmidt, SL; Vasconcelos, CCF, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karaźniewicz-Łada, M | 1 |
| Główka, AK | 1 |
| Mikulska, AA | 1 |
| Główka, FK | 1 |
| Vasconcelos, CCF | 1 |
| Hammerle, MB | 1 |
| Sales, DS | 1 |
| Rueda Lopes, FC | 1 |
| Pinheiro, PG | 1 |
| Gouvea, EG | 1 |
| Alves, MCDF | 1 |
| Pereira, TV | 1 |
| Schmidt, SL | 1 |
| Alvarenga, RMP | 1 |
| Pires, KL | 1 |
| Ulvi, A | 1 |
| Aydın, S | 1 |
| Aydın, ME | 1 |
| Vaiman, E | 1 |
| Gayduk, A | 1 |
| Strelnik, A | 1 |
| Smirnova, D | 1 |
| Davydkin, I | 1 |
| Fedyashov, I | 1 |
| Cumming, P | 1 |
| Shnayder, N | 1 |
| Nasyrova, R | 1 |
| Fırat, O | 1 |
| Yalçın, N | 1 |
| Demirkan, K | 1 |
2 reviews available for carbamazepine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
Topics: Anticonvulsants; Cannabidiol; Carbamazepine; Clobazam; COVID-19; COVID-19 Drug Treatment; Drug Inter | 2021 |
Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Carbamazepine; COVID-19; COVID-19 Drug Trea | 2022 |
3 other studies available for carbamazepine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases.
Topics: Carbamazepine; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; SARS-CoV-2; Smell | 2022 |
Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
Topics: Atenolol; Carbamazepine; COVID-19; Environmental Monitoring; Hospitals; Humans; Lipids; Pandemics; P | 2022 |
COVID-19 & antiepileptic drugs: Should we pay attention?
Topics: Anticonvulsants; Antiviral Agents; Atazanavir Sulfate; Betacoronavirus; Carbamazepine; Coronavirus I | 2020 |